NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 94 filers reported holding NATERA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $117,341,398 | -7.7% | 2,651,783 | +1.5% | 2.48% | +2.4% |
Q2 2023 | $127,089,361 | -12.4% | 2,611,783 | 0.0% | 2.42% | -19.9% |
Q1 2023 | $145,006,192 | +38.3% | 2,611,783 | +0.1% | 3.02% | +41.1% |
Q4 2022 | $104,814,898 | +8.3% | 2,609,283 | +18.1% | 2.14% | -4.1% |
Q3 2022 | $96,811,000 | +28.7% | 2,209,283 | +4.1% | 2.23% | +14.9% |
Q2 2022 | $75,214,000 | -3.6% | 2,122,283 | +10.7% | 1.94% | +20.4% |
Q1 2022 | $77,995,000 | -55.2% | 1,917,283 | +3.0% | 1.61% | -36.5% |
Q4 2021 | $173,914,000 | -16.2% | 1,862,234 | 0.0% | 2.54% | -18.8% |
Q3 2021 | $207,527,000 | +6.8% | 1,862,234 | +8.8% | 3.13% | +6.7% |
Q2 2021 | $194,390,000 | +11.8% | 1,712,234 | 0.0% | 2.93% | +8.1% |
Q1 2021 | $173,860,000 | +2.0% | 1,712,234 | 0.0% | 2.71% | -5.1% |
Q4 2020 | $170,402,000 | +37.9% | 1,712,234 | +0.1% | 2.86% | -3.9% |
Q3 2020 | $123,586,000 | +62.1% | 1,710,769 | +11.9% | 2.98% | +38.7% |
Q2 2020 | $76,242,000 | +101.7% | 1,529,128 | +20.8% | 2.14% | +31.8% |
Q1 2020 | $37,806,000 | +178.5% | 1,266,125 | +214.2% | 1.63% | +217.8% |
Q4 2019 | $13,575,000 | +44.0% | 402,953 | +40.2% | 0.51% | -8.7% |
Q3 2019 | $9,429,000 | +3255.5% | 287,470 | +807.0% | 0.56% | +658.1% |
Q1 2017 | $281,000 | -24.3% | 31,693 | 0.0% | 0.07% | -47.1% |
Q4 2016 | $371,000 | +5.4% | 31,693 | 0.0% | 0.14% | +32.1% |
Q3 2016 | $352,000 | -7.9% | 31,693 | 0.0% | 0.11% | -19.1% |
Q2 2016 | $382,000 | +26.5% | 31,693 | 0.0% | 0.13% | +19.1% |
Q1 2016 | $302,000 | -12.2% | 31,693 | 0.0% | 0.11% | +2.8% |
Q3 2015 | $344,000 | – | 31,693 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |